Showing 2,421 - 2,440 results of 14,282 for search '(( significantly higher decrease ) OR ( significantly increased decrease ))', query time: 0.41s Refine Results
  1. 2421
  2. 2422
  3. 2423
  4. 2424

    Image 4_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  5. 2425

    Image 1_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  6. 2426

    Image 3_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  7. 2427

    Image 2_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg by Gizem Yılmaz (20641691)

    Published 2025
    “…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…”
  8. 2428
  9. 2429
  10. 2430

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  11. 2431

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  12. 2432

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  13. 2433

    European study sites. by Graeme T. Swindles (7192745)

    Published 2025
    “…Furthermore, a significant relationship is observed between aPAR and water-table depth (reconstructed from testate-amoeba subfossils), suggesting that higher aPAR levels are often associated with wetter conditions. …”
  14. 2434

    Location of study sites. by Graeme T. Swindles (7192745)

    Published 2025
    “…Furthermore, a significant relationship is observed between aPAR and water-table depth (reconstructed from testate-amoeba subfossils), suggesting that higher aPAR levels are often associated with wetter conditions. …”
  15. 2435
  16. 2436
  17. 2437
  18. 2438
  19. 2439
  20. 2440